Mohamed Ettaoussi

Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I)

Mohamed Ettaoussi, Ahmed Sabaouni, Marouan Rami et al. · European Journal of Medicinal Chemistry · 2012 · 34 citations · Full text

Naphthalenic Analogues, Medicinal Chemistry, Medicine +9

Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors

Irina Kufareva, Benoît Bestgen, P. Brear et al. · Scientific Reports · 2019 · 33 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Protein Function +15

Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands

Sophie Poissonnier-Durieux, Mohamed Ettaoussi, Basile Pérès et al. · Bioorganic & Medicinal Chemistry · 2008 · 26 citations · Full text

Organic Chemistry, Chemistry, 3-Phenylnaphthalenic Derivatives +4

Photophysical, electrochemical, and spectroelectrochemical investigation of electronic<i>push–pull</i>benzothiadiazole fluorophores

Monika Wałęsa‐Chorab, Marie‐Hélène Tremblay, Mohamed Ettaoussi et al. · Pure and Applied Chemistry · 2015 · 24 citations · Full text

Organic Charge-transfer Compound, Chemical Engineering, Engineering +15

Synthesis and Pharmacological Evaluation of a series of the Agomelatine Analogues as Melatonin MT₁/MT₂ Agonist and 5‐HT_2C Antagonist

Mohamed Ettaoussi, Ahmed Sabaouni, Basile Pérès et al. · ChemMedChem · 2013 · 19 citations